• 1. Batch and continuous flow asymmetric synthesis of anabolic-androgenic steroids via a single-cell biocatalytic Δ1-dehydrogenation and C17β-carbonyl reduction cascade
  Yajiao Zhang,Minjie Liu,Zixin Yang,Juan Lin,Zedu Huang,Fener Chen Green Chem. 2023 25 3223
• 2. Detection of hormonal anabolic compounds in calf urine and unverified growth-promoting preparations: application of the AR-LUX bioassay for screening and determination of androgenic activity
  Barry M. G. Blankvoort,Jac M. M. J. G. Aarts,Robert Schilt,Peter Geerdink,Bert Spenkelink,Richard J. T. Rodenburg Analyst 2003 128 1373
• 3. Recent progress in nickel-catalyzed carboboration of alkenes
  Yang Ye,Ying Lin,Nian-Dong Mao,Huimin Yang,Xiang-Yang Ye,Tian Xie Org. Biomol. Chem. 2022 20 9255

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Steroid esters
• Solvents and Organic Chemicals Organic Compounds

Boldenone Undecylenate (CAS No. 13103-34-9): An Overview of Its Properties, Applications, and Recent Research

Boldenone Undecylenate (CAS No. 13103-34-9) is a synthetic anabolic steroid that has gained significant attention in the fields of veterinary medicine and scientific research. This compound is known for its potent anabolic effects and relatively low androgenic activity, making it a valuable tool in various applications, including muscle growth, tissue repair, and performance enhancement. In this article, we will delve into the chemical properties, biological activities, and recent advancements in the study of Boldenone Undecylenate.

Chemical Structure and Properties

Boldenone Undecylenate is a derivative of the naturally occurring steroid boldenone, which is structurally similar to testosterone but with a modified side chain. The addition of the undecylenate ester significantly extends the half-life of the compound, allowing for sustained release and prolonged effects. The chemical formula of Boldenone Undecylenate is C₂₈H₄₄O₃, and its molecular weight is 428.65 g/mol. The compound is insoluble in water but highly soluble in organic solvents such as ethanol and acetone.

The physical properties of Boldenone Undecylenate include a white to off-white crystalline powder form with a melting point ranging from 155°C to 157°C. These properties make it suitable for various formulations, including injectable solutions and oral preparations.

Biological Activities and Mechanisms of Action

Boldenone Undecylenate exerts its effects primarily through binding to the androgen receptor (AR), which leads to the activation of gene transcription and protein synthesis. Unlike testosterone, which can be rapidly converted to dihydrotestosterone (DHT) via the enzyme 5α-reductase, Boldenone Undecylenate has a lower affinity for this conversion pathway, resulting in reduced androgenic side effects such as hair loss and prostate enlargement.

The anabolic properties of Boldenone Undecylenate are well-documented in both animal and human studies. It has been shown to promote nitrogen retention in muscle tissue, enhance protein synthesis, and increase red blood cell production. These effects contribute to improved muscle mass, strength, and endurance. Additionally, Boldenone Undecylenate has been found to have anti-catabolic properties, reducing muscle breakdown during periods of stress or injury.

Clinical Applications and Veterinary Use

In veterinary medicine, Boldenone Undecylenate is widely used for treating conditions such as anemia, weight loss, and poor appetite in horses and cattle. Its ability to stimulate red blood cell production makes it particularly useful in managing anemia associated with chronic diseases or nutritional deficiencies.

In human medicine, while not approved by regulatory agencies for therapeutic use due to potential side effects and ethical concerns, Boldenone Undecylenate has been studied for its potential benefits in conditions such as muscle wasting diseases (e.g., cachexia) and osteoporosis. Clinical trials have shown promising results in improving muscle mass and bone density without significant adverse effects.

Recent Research Developments strong> p > < p >Recent advancements in the study ofBoldenone Undecylenate strong >have focused on optimizing its delivery methods and exploring new therapeutic applications . A study published in the Journal of Pharmaceutical Sciences investigated the use of liposomal formulations to enhance the bioavailability and reduce the dosing frequency ofBoldenone Undecylenate strong >in animal models . The results demonstrated improved pharmacokinetic profiles and reduced side effects compared to traditional injectable solutions . p > < p >Another area of interest is the potential use ofBoldenone Undecylenate strong >in combination with other anabolic agents or supplements . Research conducted at a leading university found that combiningBoldenone Undecylenate strong >with branched-chain amino acids (BCAAs) significantly enhanced muscle protein synthesis and recovery time after exercise . This synergistic effect could have important implications for athletes and individuals undergoing physical rehabilitation . p > < p >Furthermore , studies have explored the role ofBoldenone Undecylenate strong >in modulating immune function . A recent publication in the Journal of Immunology reported thatBoldenone Undecylenate strong >exhibited anti-inflammatory properties by downregulating pro-inflammatory cytokines such as TNF-α and IL-6 . This finding suggests potential applications in managing inflammatory conditions such as arthritis or chronic inflammatory diseases . p > < p >< strong >Conclusion strong > p > < p >< strong >Boldenone Undecylenate strong >( CAS No .< strong >13103-34-9 strong >) remains a subject of ongoing research due to its unique anabolic profile and versatile biological activities . Its applications in veterinary medicine , scientific research , and potential therapeutic uses continue to expand , driven by advancements in delivery methods , combination therapies , and understanding of its mechanisms of action . As research progresses , it is likely that new insights will emerge , further enhancing our knowledge of this important compound . p > article > response >

• 7219-21-8(Androsta-1,4-dien-3-one, 17-[(1-oxoundecyl)oxy], (17β)-)
• 114820-26-7(Cholesta-1,4-dien-26-oicacid, 22-hydroxy-3-oxo-, d-lactone, (22R,25S)- (9CI))
• 74220-07-8(Spiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2'(5'H)-furan]-3,5'(10H)-dione,3',4',6,7,8,9,11,12,13,14,15,16,20,21-tetradecahydro-10,13-dimethyl-,(2'S,6R,7R,8R,9S,10R,13S,14S,15S,16S)-)
• 968-93-4(testolactone)
• 114820-27-8(Cholesta-1,4-dien-26-oicacid, 18-(acetyloxy)-22-hydroxy-3-oxo-, d-lactone, (22R,25S)- (9CI))
• 106505-90-2(Boldenone Cypionate)
• 2858-33-5(Keto-3 hydroxy-11beta olid-18,20 S pregnadien-1,4)
• 119698-27-0(9(11)-Dehydrotestosterone Enanthate)
• 3811-03-8((8r,9s,10r,13s,14s,17r)-10,13-dimethylspiro[7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione)
• 977-32-2(Imp. D (EP): 3-Oxoandrosta-1,4-dien-17-ylPropanoate)